Overview

Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether ranibizumab is effective in the treatment of choroidal neovascularization secondary to causes other then wet macular-degeneration.

Phase:

Phase 1

Details

Lead Sponsor:

Ophthalmic Consultants of Boston

Collaborator:

Genentech, Inc.

Treatments:

Ranibizumab